Reviva Pharmaceuticals Warrants
RVPHW
RVPHW was delisted on the 12th of December, 2025.
7 hedge funds and large institutions have $285K invested in Reviva Pharmaceuticals Warrants in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.
40% more funds holding
Funds holding: 5 → 7 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
32% less capital invested
Capital invested by funds: $422K → $285K (-$137K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.5K |
| 2 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$2.91K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$87 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$9.53K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
BlueCrest Capital Management
St Helier,
Jersey
| $222K | +$2.91K | +14,400 | +1% |
|
2
Walleye Capital
New York
| $16K | – | – | – |
|
|
AI
3
Arena Investors
Purchase,
New York
| $15K | – | – | – |
|
4
Walleye Trading
New York
| $12K | – | – | – |
|
|
AA
5
AQR Arbitrage
Greenwich,
Connecticut
| $10K | -$9.53K | -47,151 | -46% |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $10K | +$11.5K | +57,064 | New |
|
|
7
UBS Group
Zurich,
Switzerland
| – | +$87 | +431 | New |
|
RVPHW Hedge Fund Activity: Q2 2022 in Review
7 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q2 2022, worth a combined $285K — down 32% from $422K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RVPHW positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $11.5K. The largest seller was AQR Arbitrage, cutting an estimated $9.53K.
- 7 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q2 2022, up from 5 in Q1 2022.
- Funds reported $285K of Reviva Pharmaceuticals Warrants stock for Q2 2022, down 32% quarter-over-quarter.
- 2 funds opened new Reviva Pharmaceuticals Warrants positions in Q2 2022 and 0 closed out, a net change of +2 holders.
- The largest Reviva Pharmaceuticals Warrants buyer in Q2 2022 was Susquehanna International Group, an estimated $11.5K added.
- The largest Reviva Pharmaceuticals Warrants seller in Q2 2022 was AQR Arbitrage, an estimated $9.53K sold.
Based on aggregated 13F filings for Q2 2022.